Taro Pharmaceutical Stock Options
| TARO Stock | USD 42.39 0.09 0.21% |
Taro Pharmaceutical's option chain provides insight into all available option contracts written on Taro Pharmaceutical's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Taro Pharmaceutical's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Taro option contract.
In The Money vs. Out of Money Option Contracts on Taro Pharmaceutical
Analyzing Taro Pharmaceutical's in-the-money options over time can help investors to take a profitable long position in Taro Pharmaceutical regardless of its overall volatility. This is especially true when Taro Pharmaceutical's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Taro Pharmaceutical's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Taro Pharmaceutical's stock while costing only a fraction of its price.
Taro Pharmaceutical's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 18 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Taro Pharmaceutical option chain provides detailed quote and price information for the current Taro Pharmaceutical Industries option contracts. It shows all of Taro Pharmaceutical's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Taro Pharmaceutical's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Taro Pharmaceutical's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Taro Pharmaceutical's option, there is no secondary market available for investors to trade.
Taro Pharmaceutical's stock options are financial instruments that give investors the right to buy or sell shares of Taro Pharmaceutical common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Taro stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Taro Pharmaceutical's stock price goes up or down, the stock options follow.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Please note that buying 'in-the-money' options on Taro Pharmaceutical lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Taro Pharmaceutical's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Taro Pharmaceutical contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Taro Stock moves the wrong way.
At this time, Taro Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 2nd of May 2024, Liabilities And Stockholders Equity is likely to grow to about 2.6 B, while Common Stock Shares Outstanding is likely to drop about 32.2 M. Taro Current Options Market Mood
Taro Pharmaceutical's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Taro Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Taro Pharmaceutical's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Taro Pharmaceutical's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Taro Pharmaceutical's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Taro contract
Base on the Rule 16, the options market is currently suggesting that Taro Pharmaceutical Industries will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-05-17 option contract. With Taro Pharmaceutical trading at USD 42.39, that is roughly USD 0.0. If you think that the market is fully incorporating Taro Pharmaceutical's daily price movement you should consider buying Taro Pharmaceutical Industries options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Taro |
Purchasing Taro Pharmaceutical options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Taro calls. Remember, the seller must deliver Taro Pharmaceutical Industries stock to the call owner when a call is exercised.
Taro Pharmaceutical Option Chain
When Taro Pharmaceutical's strike price is surpassing the current stock price, the option contract against Taro Pharmaceutical Industries stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Taro Pharmaceutical's option chain is a display of a range of information that helps investors for ways to trade options on Taro. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Taro. It also shows strike prices and maturity days for a Taro Pharmaceutical against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $22.5 | 0.9394 | 0.0058 | 0 | 2024-05-17 | 18.7 - 22.5 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.93 | 0.0076 | 0 | 2024-05-17 | 16.2 - 20.0 | 0.0 | In |
Call | 2024-05-17 CALL at $30.0 | 0.905 | 0.0133 | 0 | 2024-05-17 | 11.2 - 15.0 | 0.0 | In |
Call | 2024-05-17 CALL at $35.0 | 0.8621 | 0.0266 | 0 | 2024-05-17 | 6.2 - 10.0 | 0.0 | In |
Call | 2024-05-17 CALL at $40.0 | 0.756 | 0.0795 | 0 | 2024-05-17 | 1.15 - 5.0 | 0.0 | In |
Put | 2024-05-17 PUT at $45.0 | -0.7196 | 0.0858 | 0 | 2024-05-17 | 1.4 - 5.0 | 0.0 | In |
Put | 2024-05-17 PUT at $50.0 | -0.8163 | 0.0378 | 0 | 2024-05-17 | 6.4 - 10.0 | 0.0 | In |
Put | 2024-05-17 PUT at $55.0 | -0.8523 | 0.0244 | 0 | 2024-05-17 | 11.4 - 15.0 | 0.0 | In |
Put | 2024-05-17 PUT at $60.0 | -0.8716 | 0.0182 | 0 | 2024-05-17 | 16.4 - 20.0 | 0.0 | In |
Taro Pharmaceutical Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Taro Pharmaceutical Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Taro Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Taro Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Taro Pharmaceutical Corporate Directors
Taro Pharmaceutical corporate directors refer to members of a Taro Pharmaceutical board of directors. The board of directors generally takes responsibility for the Taro Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Taro Pharmaceutical's board members must vote for the resolution. The Taro Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jeff Holm | Executive Director Sales and Operations of Branded Pharmaceutical business | Profile | |
| Ralph Bohrer | Executive Director, Sales and Marketing, TPHA | Profile | |
| Danny Biran | Independent Director | Profile | |
| Ilana AvidovMor | Independent Director | Profile |
Already Invested in Taro Pharmaceutical Industries?
The danger of trading Taro Pharmaceutical Industries is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Taro Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Taro Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Taro Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.